Skip to content
10-Q

Quarterly Report

COGNITION THERAPEUTICS INC CGTX

0001104659-26-057545

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 89.5M sh
Shares Diluted Q1 2026 · Mar 31, 2026 89.19M sh
Shares Diluted Q1 2026 · Mar 31, 2025 61.83M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$5.54M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$9.88M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $31.13M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $36.81M
Stockholders Equity Q1 2026 · Mar 31, 2026 $29.91M
Stockholders Equity Q1 2026 · Dec 31, 2025 $34.27M
Stockholders Equity Q1 2026 · Mar 31, 2025 $12.27M
Stockholders Equity Q1 2026 · Dec 31, 2024 $18.75M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.05M
Current Liabilities Q1 2026 · Dec 31, 2025 $13.92M
Total Liabilities Q1 2026 · Mar 31, 2026 $6.23M
Total Liabilities Q1 2026 · Dec 31, 2025 $14.12M
Current Assets Q1 2026 · Mar 31, 2026 $35.81M
Current Assets Q1 2026 · Dec 31, 2025 $47.99M
Total Assets Q1 2026 · Mar 31, 2026 $36.14M
Total Assets Q1 2026 · Dec 31, 2025 $48.39M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.05
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.14
Eps Basic Q1 2026 · Mar 31, 2026 −$0.05
Eps Basic Q1 2026 · Mar 31, 2025 −$0.14
Sga Expense Q1 2026 · Mar 31, 2026 $2.7M
Sga Expense Q1 2026 · Mar 31, 2025 $2.99M
Rd Expense Q1 2026 · Mar 31, 2026 $6.12M
Rd Expense Q1 2026 · Mar 31, 2025 $10.79M
Net Income Q1 2026 · Mar 31, 2026 −$4.57M
Net Income Q1 2026 · Dec 31, 2025 −$23.49M
Net Income Q1 2026 · Mar 31, 2025 −$8.48M
Operating Income Q1 2026 · Mar 31, 2026 −$8.82M
Operating Income Q1 2026 · Mar 31, 2025 −$13.78M